Loading patent…
AssigneesInstitut National De La Sante Et De La Recherche Medicale (Inserm), Universite Claude Bernard Lyon 1
InventorsVincent Lotteau, Benoit De Chassey, Patrice Andre, Laurene Meyniel-Schicklin, Anne Aublin-Gex
Estimating the term…
The present invention relates to methods and pharmaceutical compositions for inhibiting influenza virus replication. More particularly, the present invention relates to a compound selected from the group consisting of Gemcitabine, Obatoclax Mesylate, Docetaxel, HA-14, Alsterpaullone, GSK3B inhibitor VIII, GSK3B inhibitor XV, Indirubin 3′-monoxime, L glutathione reduced, Fluocinolone acetonide, Tirofiban, Topotecan hydrochloride, Clofarabine, Vinblastine, Menadione Crystalline and derivatives or analogues thereof for use in the treatment of an influenza infection in a subject in need thereof.
A method for the treatment of an influenza infection in a subject infected by influenza virus comprising administering to the subject an effective amount of Obatoclax Mesylate.
The method according to 1 wherein the influenza virus is selected from the group consisting of H1N1, H2N2, H3N2, and H5N1.
The method according to 2 wherein the influenza virus is selected from the group consisting of H1N1, H2N2, H3N2, and H5N1.
The method according to 3 wherein the influenza virus is selected from the group consisting of H1N1, H2N2, H3N2, and H5N1.
Dependencies are inferred from the claim text.